{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T21:16:43Z","timestamp":1781990203802,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"JPSP KAKENHI","award":["18K08469"],"award-info":[{"award-number":["18K08469"]}]},{"name":"Sanwa Kagaku Kenkyusho"},{"DOI":"10.13039\/501100011746","name":"NOVARTIS Foundation (Japan) for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10456-020-09738-6","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T15:03:50Z","timestamp":1595430230000},"page":"667-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Stromal cell-derived factor 1 (SDF1) attenuates platelet-derived growth factor-B (PDGF-B)-induced vascular remodeling for adipose tissue expansion in obesity"],"prefix":"10.1007","volume":"23","author":[{"given":"Eri","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Okekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuka","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Onogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakiyo","family":"Sasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehiro","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsuneki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-8674","authenticated-orcid":false,"given":"Toshiyasu","family":"Sasaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"9738_CR1","doi-asserted-by":"publisher","first-page":"10730","DOI":"10.1073\/pnas.162349799","volume":"99","author":"MA Rupnick","year":"2002","unstructured":"Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ (2002) Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99:10730\u201310735. https:\/\/doi.org\/10.1073\/pnas.162349799","journal-title":"Proc Natl Acad Sci USA"},{"key":"9738_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nm1048","volume":"10","author":"MG Kolonin","year":"2004","unstructured":"Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W (2004) Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10:625\u2013632. https:\/\/doi.org\/10.1038\/nm1048","journal-title":"Nat Med"},{"key":"9738_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrd3055","volume":"9","author":"Y Cao","year":"2010","unstructured":"Cao Y (2010) Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 9:107\u2013115. https:\/\/doi.org\/10.1038\/nrd3055","journal-title":"Nat Rev Drug Discov"},{"key":"9738_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.12.010","author":"HK Sung","year":"2013","unstructured":"Sung HK, Doh KO, Son JE, Park JG, Bae Y, Choi S, Nelson SM, Cowling R, Nagy K, Michael IP, Koh GY, Adamson SL, Pawson T, Nagy A (2013) Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.010","journal-title":"Cell Metab"},{"key":"9738_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-019-09700-1","author":"M di Somma","year":"2019","unstructured":"di Somma M, Vliora M, Grillo E, Castro B, Dakou E, Schaafsma W, Vanparijs J, Corsini M, Ravelli C, Sakellariou E, Mitola S (2019) Role of VEGFs in metabolic disorders. Angiogenesis. https:\/\/doi.org\/10.1007\/s10456-019-09700-1","journal-title":"Angiogenesis"},{"key":"9738_CR6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.2337\/db16-0881","volume":"66","author":"Y Onogi","year":"2017","unstructured":"Onogi Y, Wada T, Kamiya C, Inata K, Matsuzawa T, Inaba Y, Kimura K, Inoue H, Yamamoto S, Ishii Y, Koya D, Tsuneki H, Sasahara M, Sasaoka T (2017) PDGFR\u03b2 regulates adipose tissue expansion and glucose metabolism via vascular remodeling in diet-induced obesity. Diabetes 66:1008\u20131021. https:\/\/doi.org\/10.2337\/db16-0881","journal-title":"Diabetes"},{"key":"9738_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41598-019-57368-w","volume":"10","author":"Y Onogi","year":"2020","unstructured":"Onogi Y, Wada T, Okekawa A, Matsuzawa T, Watanabe E, Ikeda K, Nakano M, Kitada M, Koya D, Tsuneki H, Sasaoka T (2020) Pro-inflammatory macrophages coupled with glycolysis remodel adipose vasculature by producing platelet-derived growth factor-B in obesity. Sci Rep 10:670. https:\/\/doi.org\/10.1038\/s41598-019-57368-w","journal-title":"Sci Rep"},{"key":"9738_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","volume":"124","author":"M Grunewald","year":"2006","unstructured":"Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, Chimenti S, Landsman L, Abramovitch R, Keshet E (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124:175\u2013189. https:\/\/doi.org\/10.1016\/j.cell.2005.10.036","journal-title":"Cell"},{"key":"9738_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.it.2007.05.007","volume":"28","author":"I Petit","year":"2007","unstructured":"Petit I, Jin D, Rafii S (2007) The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 28:299\u2013307. https:\/\/doi.org\/10.1016\/j.it.2007.05.007","journal-title":"Trends Immunol"},{"key":"9738_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cytogfr.2012.08.007","volume":"24","author":"AK Singh","year":"2013","unstructured":"Singh AK, Arya RK, Trivedi AK, Sanyal S, Baral R, Dormond O, Briscoe DM, Datta D (2013) Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. Cytokine Growth Factor Rev 24:41\u201349. https:\/\/doi.org\/10.1016\/j.cytogfr.2012.08.007","journal-title":"Cytokine Growth Factor Rev"},{"key":"9738_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nm1075","volume":"10","author":"DJ Ceradini","year":"2004","unstructured":"Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858\u2013864. https:\/\/doi.org\/10.1038\/nm1075","journal-title":"Nat Med"},{"key":"9738_CR12","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1002\/ijc.29655","volume":"137","author":"K Yamada","year":"2015","unstructured":"Yamada K, Maishi N, Akiyama K, Towfik Alam M, Ohga N, Kawamoto T, Shindoh M, Takahashi N, Kamiyama T, Hida Y, Taketomi A, Hida K (2015) CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property. Int J Cancer 137:2825\u20132836. https:\/\/doi.org\/10.1002\/ijc.29655","journal-title":"Int J Cancer"},{"key":"9738_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.molmed.2012.10.004","volume":"19","author":"L S\u00e1nchez-Mart\u00edn","year":"2013","unstructured":"S\u00e1nchez-Mart\u00edn L, S\u00e1nchez-Mateos P, Caba\u00f1as C (2013) CXCR7 impact on CXCL12 biology and disease. Trends Mol Med 19:12\u201322. https:\/\/doi.org\/10.1016\/j.molmed.2012.10.004","journal-title":"Trends Mol Med"},{"key":"9738_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fimmu.2015.00477","volume":"6","author":"J Zhong","year":"2015","unstructured":"Zhong J, Rajagopalan S (2015) Dipeptidyl peptidase-4 regulation of SDF-1\/CXCR4 Axis: implications for cardiovascular disease. Front Immunol 6:477. https:\/\/doi.org\/10.3389\/fimmu.2015.00477","journal-title":"Front Immunol"},{"key":"9738_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1210\/er.2014-1035","volume":"35","author":"EE Mulvihill","year":"2014","unstructured":"Mulvihill EE, Drucker DJ (2014) Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr Rev 35:992\u20131019. https:\/\/doi.org\/10.1210\/er.2014-1035","journal-title":"Endocr Rev"},{"key":"9738_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","volume":"36","author":"M Fasshauer","year":"2015","unstructured":"Fasshauer M, Bl\u00fcher M (2015) Adipokines in health and disease. Trends Pharmacol Sci 36:461\u2013470. https:\/\/doi.org\/10.1016\/j.tips.2015.04.014","journal-title":"Trends Pharmacol Sci"},{"key":"9738_CR17","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2337\/db10-1707","volume":"60","author":"D Lamers","year":"2011","unstructured":"Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, M\u00fcller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J (2011) Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60:1917\u20131925. https:\/\/doi.org\/10.2337\/db10-1707","journal-title":"Diabetes"},{"key":"9738_CR18","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.2337\/dc13-0496","volume":"36","author":"H Sell","year":"2013","unstructured":"Sell H, Bl\u00fcher M, Kl\u00f6ting N, Schlich R, Willems M, Ruppe F, Knoefel WT, Dietrich A, Fielding BA, Arner P, Frayn KN, Eckel J (2013) Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care 36:4083\u20134090. https:\/\/doi.org\/10.2337\/dc13-0496","journal-title":"Diabetes Care"},{"key":"9738_CR19","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.2337\/db16-0317","volume":"65","author":"F Zhuge","year":"2016","unstructured":"Zhuge F, Ni Y, Nagashimada M, Nagata N, Xu L, Mukaida N, Kaneko S, Ota T (2016) DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1\/M2 macrophage polarization. Diabetes 65:2966\u20132979. https:\/\/doi.org\/10.2337\/db16-0317","journal-title":"Diabetes"},{"key":"9738_CR20","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.00553.2014","volume":"309","author":"T Shinjo","year":"2015","unstructured":"Shinjo T, Nakatsu Y, Iwashita M, Sano T, Sakoda H, Ishihara H, Kushiyama A, Fujishiro M, Fukushima T, Tsuchiya Y, Kamata H, Nishimura F, Asano T (2015) DPP4 inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-\u03baB activation. Am J Physiol Endocrinol Metab 309:E214\u2013E223. https:\/\/doi.org\/10.1152\/ajpendo.00553.2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9738_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3:153\u2013165. https:\/\/doi.org\/10.1016\/j.cmet.2006.01.004","journal-title":"Cell Metab"},{"key":"9738_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fendo.2019.00389","volume":"10","author":"B Gallwitz","year":"2019","unstructured":"Gallwitz B (2019) Clinical use of DPP-4 inhibitors. Front Endocrinol (Lausanne) 10:389. https:\/\/doi.org\/10.3389\/fendo.2019.00389","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9738_CR23","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.2337\/dc06-0703","volume":"29","author":"Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE, Sitagliptin Study 021 Group","year":"2006","unstructured":"Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE, Sitagliptin Study 021 Group (2006) Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 29:2632\u20132637. https:\/\/doi.org\/10.2337\/dc06-0703","journal-title":"Diabetes Care"},{"key":"9738_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1463-1326.2006.00704.x","volume":"19","author":"Nauck MA, Meininger G, Sheng D, Terranella L, Stein PP, Sitagliptin Study 024 Group","year":"2007","unstructured":"Nauck MA, Meininger G, Sheng D, Terranella L, Stein PP, Sitagliptin Study 024 Group (2007) Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. Diabetes Obes Metab 19:194\u2013205. https:\/\/doi.org\/10.1111\/j.1463-1326.2006.00704.x","journal-title":"Diabetes Obes Metab"},{"key":"9738_CR25","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/dom.12933","volume":"19","author":"Y Terauchi","year":"2017","unstructured":"Terauchi Y, Yamada Y, Ishida H, Ohsugi M, Kitaoka M, Satoh J, Yabe D, Shihara N, Seino Y (2017) Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged \u2265 60 years (START-J trial). Diabetes Obes Metab 19:1188\u20131192. https:\/\/doi.org\/10.1111\/dom.12933","journal-title":"Diabetes Obes Metab"},{"key":"9738_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/JOE-17-0351","volume":"235","author":"T Wada","year":"2017","unstructured":"Wada T, Ishikawa A, Watanabe E, Nakamura Y, Aruga Y, Hasegawa H, Onogi Y, Honda H, Nagai Y, Takatsu K, Ishii Y, Sasahara M, Koya D, Tsuneki H, Sasaoka T (2017) Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance. J Endocrinol 235:179\u2013191. https:\/\/doi.org\/10.1530\/JOE-17-0351","journal-title":"J Endocrinol"},{"key":"9738_CR27","doi-asserted-by":"publisher","first-page":"E445","DOI":"10.1152\/ajpendo.00638.2011","volume":"303","author":"R Yonezawa","year":"2012","unstructured":"Yonezawa R, Wada T, Matsumoto N, Morita M, Sawakawa K, Ishii Y, Sasahara M, Tsuneki H, Saito S, Sasaoka T (2012) Central versus peripheral impact of estradiol on the impaired glucose metabolism in ovariectomized mice on a high-fat diet. Am J Physiol Endocrinol Metab 303:E445\u2013E456. https:\/\/doi.org\/10.1152\/ajpendo.00638.2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9738_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230885","author":"A Ishikawa","year":"2020","unstructured":"Ishikawa A, Wada T, Nishimura S, Ito T, Okekawa A, Onogi Y, Watanabe E, Sameshima A, Tanaka T, Tsuneki H, Saito S, Sasaoka T (2020) Estrogen regulates sex-specific localization of regulatory T cells in adipose tissue of obese female mice. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0230885","journal-title":"PLoS ONE"},{"key":"9738_CR29","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2014.05.012","volume":"157","author":"YS Lee","year":"2014","unstructured":"Lee YS, Kim JW, Osborne O, Oh DY, Sasik R, Schenk S, Chen A, Chung H, Murphy A, Watkins SM, Quehenberger O, Johnson RS, Olefsky JM (2014) Increased adipocyte O2 consumption triggers HIF-1\u03b1, causing inflammation and insulin resistance in obesity. Cell 157:1339\u20131352. https:\/\/doi.org\/10.1016\/j.cell.2014.05.012","journal-title":"Cell"},{"key":"9738_CR30","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.2337\/db16-0012","volume":"65","author":"A Takikawa","year":"2016","unstructured":"Takikawa A, Mahmood A, Nawaz A, Kado T, Okabe K, Yamamoto S, Aminuddin A, Senda S, Tsuneyama K, Ikutani M, Watanabe Y, Igarashi Y, Nagai Y, Takatsu K, Koizumi K, Imura J, Goda N, Sasahara M, Matsumoto M, Saeki K, Nakagawa T, Fujisaka S, Usui I, Tobe K (2016) HIF-1\u03b1 in myeloid cells promotes adipose tissue remodeling toward insulin resistance. Diabetes 65:3649\u20133659. https:\/\/doi.org\/10.2337\/db16-0012","journal-title":"Diabetes"},{"key":"9738_CR31","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00125-013-2885-1","volume":"56","author":"S Fujisaka","year":"2013","unstructured":"Fujisaka S, Usui I, Ikutani M, Aminuddin A, Takikawa A, Tsuneyama K, Mahmood A, Goda N, Nagai Y, Takatsu K, Tobe K (2013) Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1\u03b1-dependent and HIF-1\u03b1-independent manner in obese mice. Diabetologia 56:1403\u20131412. https:\/\/doi.org\/10.1007\/s00125-013-2885-1","journal-title":"Diabetologia"},{"key":"9738_CR32","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1128\/MCB.00192-09","volume":"29","author":"N Halberg","year":"2009","unstructured":"Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE (2009) Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29:4467\u20134483. https:\/\/doi.org\/10.1128\/MCB.00192-09","journal-title":"Mol Cell Biol"},{"key":"9738_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cmet.2011.08.006","volume":"14","author":"KY Lee","year":"2011","unstructured":"Lee KY, Gesta S, Boucher J, Wang XL, Kahn CR (2011) The differential role of Hif1\u03b2\/Arnt and the hypoxic response in adipose function, fibrosis, and inflammation. Cell Metab 14:491\u2013503. https:\/\/doi.org\/10.1016\/j.cmet.2011.08.006","journal-title":"Cell Metab"},{"key":"9738_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2337\/db16-0317","volume":"555","author":"DS Ghorpade","year":"2018","unstructured":"Ghorpade DS, Ozcan L, Zheng Z, Nicoloro SM, Shen Y, Chen E, Bl\u00fcher M, Czech MP, Tabas I (2018) Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature 555:673\u2013677. https:\/\/doi.org\/10.2337\/db16-0317","journal-title":"Nature"},{"key":"9738_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cmet.2018.10.001","volume":"29","author":"EM Varin","year":"2019","unstructured":"Varin EM, Mulvihill EE, Beaudry JL, Pujadas G, Fuchs S, Tanti JF, Fazio S, Kaur K, Cao X, Baggio LL, Matthews D, Campbell JE, Drucker DJ (2019) Circulating levels of soluble dipeptidyl peptidase-4 are dissociated from inflammation and induced by enzymatic DPP4 inhibition. Cell Metab 29:320\u2013334. https:\/\/doi.org\/10.1016\/j.cmet.2018.10.001","journal-title":"Cell Metab"},{"key":"9738_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/cvr\/cvx203","volume":"114","author":"OJ Ziff","year":"2018","unstructured":"Ziff OJ, Bromage DI, Yellon DM, Davidson SM (2018) Therapeutic strategies utilizing SDF-1\u03b1 in ischaemic cardiomyopathy. Cardiovasc Res 114:358\u2013367. https:\/\/doi.org\/10.1093\/cvr\/cvx203","journal-title":"Cardiovasc Res"},{"key":"9738_CR37","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1096\/fj.14-249797","volume":"28","author":"L Yao","year":"2014","unstructured":"Yao L, Heuser-Baker J, Herlea-Pana O, Zhang N, Szweda LI, Griffin TM, Barlic-Dicen J (2014) Deficiency in adipocyte chemokine receptor CXCR4 exacerbates obesity and compromises thermoregulatory responses of brown adipose tissue in a mouse model of diet-induced obesity. FASEB J 28:4534\u20134550. https:\/\/doi.org\/10.1096\/fj.14-249797","journal-title":"FASEB J"},{"key":"9738_CR38","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2337\/db17-0706","volume":"67","author":"J Shin","year":"2018","unstructured":"Shin J, Fukuhara A, Onodera T, Kita S, Yokoyama C, Otsuki M, Shimomura I (2018) SDF-1 is an autocrine insulin-desensitizing factor in adipocytes. Diabetes 67:1068\u20131078. https:\/\/doi.org\/10.2337\/db17-0706","journal-title":"Diabetes"},{"key":"9738_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cyto.2018.02.024","volume":"109","author":"KE Quinn","year":"2018","unstructured":"Quinn KE, Mackie DI, Caron KM (2018) Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology. Cytokine 109:17\u201323. https:\/\/doi.org\/10.1016\/j.cyto.2018.02.024","journal-title":"Cytokine"},{"key":"9738_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bcp.2017.03.009","volume":"132","author":"R Janssens","year":"2018","unstructured":"Janssens R, Mortier A, Boff D, Ruytinx P, Gouwy M, Vantilt B, Larsen O, Daugvilaite V, Rosenkilde MM, Parmentier M, Noppen S, Liekens S, Van Damme J, Struyf S, Teixeira MM, Amaral FA, Proost P (2018) Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes. Biochem Pharmacol 132:92\u2013101. https:\/\/doi.org\/10.1016\/j.bcp.2017.03.009","journal-title":"Biochem Pharmacol"},{"key":"9738_CR41","doi-asserted-by":"publisher","first-page":"eaaw3657","DOI":"10.1126\/scisignal.aaw3657","volume":"12","author":"M Gustavsson","year":"2019","unstructured":"Gustavsson M, Dyer DP, Zhao C, Handel TM (2019) Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding. Sci Signal 12:eaaw3657. https:\/\/doi.org\/10.1126\/scisignal.aaw3657","journal-title":"Sci Signal"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-020-09738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-020-09738-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-020-09738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T23:58:49Z","timestamp":1626911929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-020-09738-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["9738"],"URL":"https:\/\/doi.org\/10.1007\/s10456-020-09738-6","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"14 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}